Charles River Laboratories International inc

CRL's Fundamental analysis

Select the Comparisons :

None ▼

Select the Ratio:

None▼

None ▼

None▼

CRL Growth rates comparisons

Looking into Charles River Laboratories International Inc growth rates, revenue grew by 21.52 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 1663

Medical Laboratories industry recorded deterioration of revenues by -1.89 %

Charles River Laboratories International Inc 's net income grew by 35.24 % in IV. Quarter 2022 year on year, above company average,

• More on CRL's Growth

CRL's Valuation comparisons

Charles River Laboratories International Inc
current PE on trailing twelve month basis is below Medical Laboratories industry average.

Charles River Laboratories International Inc PEG ratio is at 0.83 Charles River Laboratories International Inc realized cash outflow of $ -0.1per share in trailing twelve-month period.

Company

20.93

PE TTM

Industry

28.78

PE TTM

Company's Price to Sales ratio is at 2.56.
Medical Laboratories industry's Price to Sales ratio is at 2.14.

• More on CRL's Valuation

Total Debt (Millions $)	2,708
Dividend TTM ($)	0 $
Dividend Yield TTM (%)	-
Revenue/Employee (TTM) $	-
Net Income/Employee (TTM) $	-
Receivable Turnover (TTM)	5.36
Tangible Book Value (Per Share $)	-16.07

CRL's Valuation comparisons

Company

20.93

PE TTM

Industry

28.78

PE TTM

Company's Price to Sales ratio is at 2.56.
Medical Laboratories industry's Price to Sales ratio is at 2.14.

Charles River Laboratories International Inc Price to Book Ratio is at 3.42 lower than Indusry Avg. of 360.13. and higher than S&P 500 Avg. of -0.01

• More on CRL's Valuation

• Market Capitalization (Millions $)	10,190
• Shares Outstanding (Millions)	51
• Employees	-
• Revenues (TTM) (Millions $)	3,976
• Net Income (TTM) (Millions $)	493
• Cash Flow (TTM) (Millions $)	-5
• Capital Exp. (TTM) (Millions $)	-325
• Total Debt (Millions $)	2,708
• Dividend TTM ($)	0 $
• Dividend Yield TTM (%)	-
• Revenue/Employee (TTM) $	-
• Net Income/Employee(TTM) $	-
• Receivable Turnover Ratio (TTM)	5.36
• Tangible Book Value (Per Share $)	-16.07

• Market Capitalization (Millions $)	10,190
• Shares Outstanding (Millions)	51
• Employees	-
• Revenues (TTM) (Millions $)	3,976
• Net Income (TTM) (Millions $)	493
• Cash Flow (TTM) (Millions $)	-5
• Capital Exp. (TTM) (Millions $)	-325

CRL's Profitability Comparisons
Charles River Laboratories International Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2022 to 14.89 % from 15.26 % in III. Quarter. Charles River Laboratories International Inc net profit margin of 17.19 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 65 in Healthcare sector and number 820 in S&P 500.

	*Ratio*
• Capital Ratio (MRQ)	1.74
• Total Debt to Equity (MRQ)	0.91
• Tangible Leverage Ratio (MRQ)	-
• Asset Turnover Ratio (TTM)	0.53
• Inventory Turnover Ratio (TTM)	8.61

CRL's Profitability Comparisons

Charles River Laboratories International Inc faced margin deterioraten, primarily through cost control. Operating Margin fell in IV. Quarter 2022 to 14.89 % from 15.26 % in III. Quarter.

Charles River Laboratories International Inc net profit margin of 17.19 % is currently ranking no. 6 in Medical Laboratories industry, ranking no. 65 in Healthcare sector and number 820 in S&P 500.

• More on CRL's Key Ratios


Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar TSVT's Profile Stock Price TSVT's Financials Business Description Fundamentals Charts & Quotes TSVT's News Suppliers TSVT's Competitors Customers & Markets Economic Indicators TSVT's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071